What we're reading, April 6, 2016: the federal government could be doing more to alert uninsured individuals about their eligibility for subsidies; the White House will transfer leftover Ebola funds to combat the Zika virus; and Senate companion bill to 21st Century Cures Act is almost done.
A new study from the Urban Institute determined that the Internal Revenue Service could help identify people who are eligible for, but not receiving, government assistance to buy health coverage. Kaiser Health News reported that approximately half of the uninsured people receiving the earned income tax credit are eligible for assistance to buy health insurance. Some local governments make efforts to identify the uninsured, but the federal government could do more by using the data it collects from other assistance programs.
The White House will transfer money left over from the fight against Ebola to the fund to combat the Zika virus, reported the Wall Street Journal. The majority of the funding will go to the CDC, which focuses on research and development of anti-Zika vaccines and treating those infected. Before Congress went on spring recess, the administration requested emergency funding to combat Zika, but Congress went on break without voting. The Senate returned on April 4, but the House doesn’t return until April 12.
A companion to the 21st Century Cures Act could reach the Senate next week. The House passed the 21st Century Cures Act and the new bill is the Senate’s companion legislation. According to The Hill, the biggest obstacle had been finding a way to pay for funding for medical research at the National Institutes of Health. The exact dollar amount for the funding hasn’t been settled yet, but it will likely be close to $9 billion over 5 years, which was the amount in the House bill.
Government agencies have created an online portal for the public to report potential anticompetitive practices in health care; there are changes coming to the “boxed warning” section for chimeric antigen receptor T-cell therapies (CAR T) to highlight T-cell blood cancer risk; questions about the safety of obesity medications during pregnancy have arisen in women on them who previously struggled with fertility issues.
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Drs Raymond Thertulien, Joseph Mikhael on Racial Disparities in Multiple Myeloma Care Access
December 28th 2023In the wake of the 2023 American Society of Hematology Annual Meeting and Exposition, Raymond Thertulien, MD, PhD, of Novant Health, and Joseph Mikhael, MD, MEd, FRCPC, FACP, chief medical officer of the International Myeloma Foundation, discussed health equity research highlights from the meeting and drivers of racial disparities in multiple myeloma outcomes.
Listen
Pegcetacoplan for PNH More Cost-Effective Than Anti-C5 Monoclonal Antibodies
April 18th 2024A cost-utility analysis conducted from the perspective of the Italian health system found that pegcetacoplan was more effective and less costly than 2 complement 5 (C5) inhibitors for the treatment of paroxysmal nocturnal hemoglobinuria (PNH).
Read More